Title: Personalized and precision medicine as a unique healthcare model through the view of biodesign and transla onal armamentarium of the newest genera on

Biography:

S Suchkov graduated from Astrakhan State Medical University in 1980 and was awarded with MD. In 1985, he completed PhD from I M Sechenov Moscow Medical Academy and Ins tute of Medical Enzymology. In 2001, he completed his Doctor Degree at the Na onal Ins tute of Immunology, Russia. From 1989 to 1995, he was Head of the Lab of Clinical Immunology, Helmholtz Eye Research Ins tute in Moscow. From 1995 through 2004, he is a Chair of the Dept. for Clinical Immunology, Moscow Clinical Research Ins tute (MONIKI). In 1993-1996, he was a Secretary-in-Chief of the Editorial Board, Biomedical Science, an interna onal journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. At present, he is Professor and Chair, Department for Personalized and Transla onal Medicine, I M Sechenov First Moscow State Medical University and Department of Clinical Immunology, A I Evdokimov Moscow State Medical and Dental University. He is a member of the Editorial Boards of Open Journal of Immunology, EPMAJ, American J of Cardiovascular Research and Personalized Medicine Universe. He was the Head of the Lab of Clin Immunol at Helmholtz Eye Res Inst in Moscow from 1989 to 1995. He was a Chair in the Dept. for Clin Immunol at Moscow Reg Clin Res Inst from 1995 to 2004. He has been trained at: NIH; Wills Eye Hospital, PA, USA; University of Florida in Gainesville; UCSF, S-F, CA, USA; Johns Hopkins University, Bal more, MD, USA. He was an Execu ve Secretary-in-Chief of the Editorial Board, Biomedical Science, an interna onal journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. At present, he is a Director of the Center for Personalized Medicine, Sechenov University and Chair in the Dept. for Transla onal Medicine at Moscow Engineering Physical Ins tute (MEPhI), Russia. He is a member of New York Academy of Sciences, USA; American Chemical Society (ACS), USA; American Heart Associa on (AHA), USA; EPMA (European Associa on for Predic ve, Preven ve and Personalized Medicine), Brussels, EU; ARVO (American Associa on for Research in Vision and Ophthalmology); ISER (Interna onal Society for Eye Research); PMC (Personalized Medicine Coali on), Washington, USA

Abstract

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). To achieve the implementa on of PM concept, it is necessary to create a fundamentally new strategy based upon the subclinical recogni on of biopredictors of hidden abnormali es long before the disease clinically manifests itself. Each decisionmaker values the impact of their decision to use PPM on their own budget and well-being, which may not necessarily be op mal for society as a whole. It would be extremely useful to integrate data harves ng from diff erent databanks for applica ons such as predic on and personaliza on of further treatment to thus provide more tailored measures for the
pa ents resul ng in improved pa ent outcomes, reduced adverse events, and more cost eff ec ve use of health care resources. A lack of medical guidelines has been iden fi ed by the majority of responders as the predominant barrier for adop on, indica ng a need for the development of best prac ces and guidelines to support the implementa on of PPM!  Implementa on of PPM requires a lot before the current model “physician-pa ent” could be gradually displaced by a new model “medical advisor-healthy person-at-risk”. This is the reason for developing global scien fi c, clinical, social, and educa onal projects in the area of PPM to elicit the content of the new branch.